Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy
ConclusionrhGH and GnRH analogues therapy, when indicated, though failing to induce catch-up growth, prevented further height loss leading to a FH within the normal range but still below MPH, this latter being statistically significant in children who received craniospinal and TBI.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Childhood Cancer | Children | Endocrinology | Hormonal Therapy | Hormones | Statistics | Study